Drew Moghanaki

MD, MPH, FASTRO - Lung Cancer Specialist & Endowed Thoracic Oncology Research Chair, UCLA | Co-Director, Lung Precision Oncology Pgm, VA Greater Los Angeles

[Drew Moghanaki @DrewMoghanaki]

Lung cancer needs to be prioritized as one of America’s top-5 public health problems. Learn how the VA understands this and is addressing it through a national initiative known as LPOP: https://t.co/swCMZ4060h

[Drew Moghanaki @DrewMoghanaki]

He’s the bomb. UCLA is very happy to have him on the team. Brightens every room he enters. @JieDengMDPhD

[Jeff White @PRJeffWhite]

One of the most satisfying & moving parts of my job is seeing how residence progress in their careers. I love to root them on and cheer for them.

I met Kekoa in 2017 and am so proud of him and all he’s doing in cancer care today. 👏👏

[Drew Moghanaki @DrewMoghanaki]

@PRJeffWhite @ChikaMaduMD1 Never a pretender.

[Drew Moghanaki @DrewMoghanaki]

Freddie has been officially immortalized. He will always be remembered for his vision, commitment, and passion in working with Jenny Donovan and the rest of the ProtecT team to forever change the way we think about men affected by prostate cancer. I remain deeply saddened to learn he has pancreatic cancer, yet so happy he’s still doing well 5 years after the diagnosis. @QuinteTBristol @NehaVapiwala @TylerSbrt

[Drew Moghanaki @DrewMoghanaki]

VIDEO for Dr. Hamdy’s inspiring acceptance: https://t.co/7ZutAbuSZ7

[Drew Moghanaki @DrewMoghanaki]

If you enjoy learning about translational biology in #radonc, follow these 3 accounts below. #ASTRO26

[C. Jillian Tsai, MD, PhD @CJTsaiMDPhD]

@DrewMoghanaki Thanks for attending. It is such a treat to listen to the talks by @jeremy_setton, @Samuel_Bakhoum, @SeanPitroda - wow what a panel of stars. ⭐️ so glad we got to do this.

[Drew Moghanaki @DrewMoghanaki]

I was wondering what happened to you. Similar BS happened to @TylerSbrt.

Good account for #radonc to follow.

[Stathis K @StathisKX]

@x suspended my account @stathisktw for no reason. I appealed, their AI admitted it was a mistake and claimed the account was restored but it is still suspended. I lost all of my bookmarks. Now I am saving everything In @obsidian and building my own decentralized personal knowledge base.

[Drew Moghanaki @DrewMoghanaki]

@MuzamilArshad18 @HardenedBeam @StathisKX Look into MIM. They are the industry standard with unparalleled one-click fusion. Best customer service too in radonc.

[Drew Moghanaki @DrewMoghanaki]

@StathisKX Have you looked into MIM as a complement to ARIA?

[Drew Moghanaki @DrewMoghanaki]

🚨 Team UCLA supporting @MichelleEalaMD presenting the world’s largest series of Percutaneous HDR Brachyablation for very high-risk primary and metastatic lung tumors. Even Chuck Simone was surprised by the 98.3% LC rate with median f/u of nearly 3 years. New std of care? PTX rate (7%) was lower than thermal ablation, with G3 AE 0.7%. #ASTRO26

[Drew Moghanaki @DrewMoghanaki]

She basically said, stop complaining and DO SOMETHING! @arbmckee

[Lauren Henke, MD, MSCI @lauren_henke]

@NehaVapiwala speaking now in her #ASTRO26 Presidential address, giving us all an immediate call to action to get out of the basement and better communicate the strengths of our field 💪🏼 @ASTRO_org

[Drew Moghanaki @DrewMoghanaki]

@rweichselbaum @SeanPitroda @_ShankarSiva @CJTsaiMDPhD @DrAlexLouie @KatieKeaneMD @HenningWillers How does that explain this study? https://t.co/MrNqrhq9nz

[Drew Moghanaki @DrewMoghanaki]

Sean Pitroda, whose work has raised concerns about the Badscopal effect, shares a few words of wisdom at #ASTRO26. Including the importance of total metastatic ablation of all visible sites in case irradiation of one tumor signals another unirradiated to grow.

[Drew Moghanaki @DrewMoghanaki]

All hands on deck in Canada and the US to offer patients with stage IV NSCLC an opportunity to enroll into the phase III CURB2 trial. #ASTRO26

[Drew Moghanaki @DrewMoghanaki]

Great take home points by @CJTsaiMDPhD regarding how to think about SBRT for oligoprogressive stage IV NSCLC. For those who aren’t aware, she’s the PI of the CURB & CURB2 randomized trials. #ASTRO26

[Drew Moghanaki @DrewMoghanaki]

Critical slides from today’s update at #ASTRO26 on MDT-BRIDGE to better understand what happened to the 7/50 (14%) pts with borderline resectable stage III NSCLC who all could’ve been treated with CRT, but never got any local tx after enrolling in this study that started them on nCIO. @sueyom @StephenVLiu

[Drew Moghanaki @DrewMoghanaki]

Post-hoc and conclusions.

[Drew Moghanaki @DrewMoghanaki]

TRIDENT Study: Sad to see another negative phase III study for GBM with post-op TTF with nearly 1,000 randomized. Post-hoc analysis suggests variable compliance may have confounded the primary analysis. #ASTRO26 1/

[Drew Moghanaki @DrewMoghanaki]

VIDEO for Dr. Hamdy’s inspiring acceptance: https://t.co/7ZutAbuSZ7

[Drew Moghanaki @DrewMoghanaki]

Congratulations to Freddie Hamdy for receiving the ASTRO 2026 Honorary Membership award. #ASTRO26 https://t.co/IhStrHYqZ8

[Drew Moghanaki @DrewMoghanaki]

VIDEO for Dr. Siebert’s tribute: https://t.co/wvyVYISJ6I